Word

TADAQOR

Status

Dead

Status Code

606

Status Date

Monday, January 8, 2024

Serial Number

97461837

Mark Type

4000

Filing Date

Thursday, June 16, 2022

Published for Opposition

Tuesday, April 11, 2023

Abandoned Date

Monday, January 8, 2024

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events

Jan 8, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 8, 2024

Abandonment - No Use Statement Filed

Jun 6, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 11, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 11, 2023

Published For Opposition

Mar 22, 2023

Notification Of Notice Of Publication E-Mailed

Mar 3, 2023

Approved For Pub - Principal Register

Feb 28, 2023

Assigned To Examiner

Jul 5, 2022

New Application Office Supplied Data Entered

Jun 20, 2022

New Application Entered